Pharmacogenetics 1994-02-01

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.

A E Rettie, L C Wienkers, F J Gonzalez, W F Trager, K R Korzekwa

Index: Pharmacogenetics 4(1) , 39-42, (1994)

Full Text: HTML

Abstract

Related Compounds

  • 6-hydroxy Warfarin
  • 4 hydroxy tolbutam...
  • 7-hydroxy Warfarin

Related Articles:

Investigation of two-dimensional high performance liquid chromatography approaches for reversed phase resolution of warfarin and hydroxywarfarin isomers.

2014-10-10

[J. Chromatogr. A. 1363 , 200-6, (2014)]

Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

2010-05-17

[Chem. Res. Toxicol. 23(5) , 939-45, (2010)]

Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins.

2012-09-01

[Drug Metab. Lett. 6(3) , 157-64, (2012)]

Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.

2015-01-01

[J. Pharm. Sci. 104(1) , 244-56, (2014)]

Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

2012-01-01

[J. Pharmacol. Exp. Ther. 340(1) , 46-55, (2012)]

More Articles...